Published in Biochem Biophys Res Commun on January 13, 1997
Simple cDNA normalization using kamchatka crab duplex-specific nuclease. Nucleic Acids Res (2004) 3.99
Decoding the fine-scale structure of a breast cancer genome and transcriptome. Genome Res (2006) 2.09
Mirror orientation selection (MOS): a method for eliminating false positive clones from libraries generated by suppression subtractive hybridization. Nucleic Acids Res (2000) 1.23
Amplified RNA degradation in T7-amplification methods results in biased microarray hybridizations. BMC Genomics (2003) 1.16
Suppression subtractive hybridization: a method for generating differentially regulated or tissue-specific cDNA probes and libraries. Proc Natl Acad Sci U S A (1996) 11.80
An improved PCR method for walking in uncloned genomic DNA. Nucleic Acids Res (1995) 8.66
Human catechol-O-methyltransferase haplotypes modulate protein expression by altering mRNA secondary structure. Science (2006) 6.71
Reverse transcriptase template switching: a SMART approach for full-length cDNA library construction. Biotechniques (2001) 5.92
Amplification of cDNA ends based on template-switching effect and step-out PCR. Nucleic Acids Res (1999) 3.70
Synthesis, deprotection, analysis and purification of RNA and ribozymes. Nucleic Acids Res (1995) 3.59
Chemical synthesis of biologically active oligoribonucleotides using beta-cyanoethyl protected ribonucleoside phosphoramidites. Nucleic Acids Res (1990) 3.58
Total chemical synthesis of a 77-nucleotide-long RNA sequence having methionine-acceptance activity. Proc Natl Acad Sci U S A (1988) 3.45
"Fluorescent timer": protein that changes color with time. Science (2000) 3.42
PCR-based subtractive hybridization and differences in gene content among strains of Helicobacter pylori. Proc Natl Acad Sci U S A (1998) 2.93
Derivatization of controlled pore glass beads for solid phase oligonucleotide synthesis. Biotechniques (1988) 2.93
A ubiquitous family of putative gap junction molecules. Curr Biol (2000) 2.77
Cortical upper layer neurons derive from the subventricular zone as indicated by Svet1 gene expression. Development (2001) 2.37
Labile exocyclic amine protection of nucleosides in DNA, RNA and oligonucleotide analog synthesis facilitating N-deacylation, minimizing depurination and chain degradation. Biochimie (1993) 2.34
Suppression subtractive hybridization: a versatile method for identifying differentially expressed genes. Methods Enzymol (1999) 2.30
The structural basis of hammerhead ribozyme self-cleavage. Cell (1998) 2.20
The molecular structure of the complex of Hoechst 33258 and the DNA dodecamer d(CGCGAATTCGCG). Nucleic Acids Res (1988) 2.07
Influence of psychological factors on risk of temporomandibular disorders. J Dent Res (2007) 2.02
Characterization of HIV-1 REV protein: binding stoichiometry and minimal RNA substrate. Nucleic Acids Res (1991) 1.96
Specificity for aminoacylation of an RNA helix: an unpaired, exocyclic amino group in the minor groove. Science (1991) 1.96
Equalizing cDNA subtraction based on selective suppression of polymerase chain reaction: cloning of Jurkat cell transcripts induced by phytohemaglutinin and phorbol 12-myristate 13-acetate. Anal Biochem (1996) 1.94
RNA hydration: a detailed look. Biochemistry (1996) 1.93
Conformational influence of the ribose 2'-hydroxyl group: crystal structures of DNA-RNA chimeric duplexes. Biochemistry (1993) 1.91
Relationship between 2'-hydroxyls and magnesium binding in the hammerhead RNA domain: a model for ribozyme catalysis. Biochemistry (1991) 1.75
Caveolin-1 is down-regulated in human ovarian carcinoma and acts as a candidate tumor suppressor gene. Am J Pathol (2001) 1.67
Prevention of guanine modification and chain cleavage during the solid phase synthesis of oligonucleotides using phosphoramidite derivatives. Nucleic Acids Res (1986) 1.67
Gene expression profiling in postmortem Rett Syndrome brain: differential gene expression and patient classification. Neurobiol Dis (2001) 1.59
Anticancer effects of gallic acid isolated from Indonesian herbal medicine, Phaleria macrocarpa (Scheff.) Boerl, on human cancer cell lines. Int J Oncol (2007) 1.55
TaqStart Antibody: "hot start" PCR facilitated by a neutralizing monoclonal antibody directed against Taq DNA polymerase. Biotechniques (1994) 1.54
Full-length cDNA cloning and determination of mRNA 5' and 3' ends by amplification of adaptor-ligated cDNA. Biotechniques (1996) 1.52
Minimum ribonucleotide requirement for catalysis by the RNA hammerhead domain. Biochemistry (1992) 1.52
Enzymatic aminoacylation of single-stranded RNA with an RNA cofactor. Proc Natl Acad Sci U S A (1991) 1.46
Endoscopic ultrasound miniprobe-guided steroid injection for treatment of refractory esophageal strictures. Endoscopy (1997) 1.46
Stress-induced secretion of growth inhibitors: a novel tumor suppressor function of p53. Oncogene (1998) 1.40
Mixed DNA/RNA polymers are cleaved by the hammerhead ribozyme. Biochemistry (1990) 1.35
Modified acid guanidinium thiocyanate-phenol-chloroform RNA extraction method which greatly reduces DNA contamination. Nucleic Acids Res (1993) 1.30
The 2,6-diaminopurine riboside.5-methylisocytidine wobble base pair: an isoenergetic substitution for the study of G.U pairs in RNA. Biochemistry (1994) 1.29
Use of binding energy by an RNA enzyme for catalysis by positioning and substrate destabilization. Proc Natl Acad Sci U S A (1995) 1.27
A monomeric red fluorescent protein with low cytotoxicity. Nat Commun (2012) 1.22
RhoA and RhoC proteins promote both cell proliferation and cell invasion of human oesophageal squamous cell carcinoma cell lines in vitro and in vivo. Eur J Cancer (2006) 1.20
First autologous hematopoietic SCT for ankylosing spondylitis: a case report and clues to understanding the therapy. Bone Marrow Transplant (2012) 1.19
Rescue of abasic hammerhead ribozymes by exogenous addition of specific bases. Proc Natl Acad Sci U S A (1996) 1.18
Assessment of the accuracy of a three-dimensional imaging system for archiving dental study models. J Orthod (2003) 1.16
Crystal structures of an A-form duplex with single-adenosine bulges and a conformational basis for site-specific RNA self-cleavage. Chem Biol (1996) 1.14
Use of SMART-generated cDNA for gene expression studies in multiple human tumors. Biotechniques (2001) 1.13
Structure and regulation of the mouse ing1 gene. Three alternative transcripts encode two phd finger proteins that have opposite effects on p53 function. J Biol Chem (1999) 1.12
Comt1 genotype and expression predicts anxiety and nociceptive sensitivity in inbred strains of mice. Genes Brain Behav (2010) 1.09
Quantitating tertiary binding energies of 2' OH groups on the P1 duplex of the Tetrahymena ribozyme: intrinsic binding energy in an RNA enzyme. Biochemistry (1997) 1.09
Crystal structure of an Okazaki fragment at 2-A resolution. Proc Natl Acad Sci U S A (1992) 1.09
The crystal structure of r(CCCCGGGG) in two distinct lattices. Biochemistry (1995) 1.04
Template-directed ligation of peptides to oligonucleotides. Chem Biol (1996) 1.03
Chemically modified hammerhead ribozymes with improved catalytic rates. Biochemistry (1996) 1.03
Base and sugar requirements for RNA cleavage of essential nucleoside residues in internal loop B of the hairpin ribozyme: implications for secondary structure. Nucleic Acids Res (1996) 1.02
Ribozyme-catalyzed primer extension by trinucleotides: a model for the RNA-catalyzed replication of RNA. Biochemistry (1993) 1.00
cDNA expression array reveals heterogeneous gene expression profiles in three glioblastoma cell lines. Oncogene (1999) 0.99
Chemical synthesis of oligoribonucleotides containing 2-aminopurine: substrates for the investigation of ribozyme function. J Org Chem (1990) 0.97
Template-directed primer extension catalyzed by the Tetrahymena ribozyme. Mol Cell Biol (1991) 0.96
Heightened expression of the cytotoxicity receptor NKG2D correlates with acute and chronic nephropathy after kidney transplantation. Am J Transplant (2006) 0.96
Differential screening of a subtracted cDNA library: a method to search for genes preferentially expressed in multiple tissues. Biotechniques (1997) 0.94
Synthesis of RNA containing inosine: analysis of the sequence requirements for the 5' splice site of the Tetrahymena group I intron. Nucleic Acids Res (1991) 0.93
Effect of structural modifications on the activity of the leadzyme. Biochemistry (1997) 0.93
Optimizing the cell efficacy of synthetic ribozymes. Site selection and chemical modifications of ribozymes targeting the proto-oncogene c-myb. J Biol Chem (1996) 0.92
Expression of PTTG and prc1 genes during telencephalic neurogenesis. Mech Dev (2000) 0.91
Ordered differential display: a simple method for systematic comparison of gene expression profiles. Nucleic Acids Res (1997) 0.91
Inhibition of vascular smooth muscle cell proliferation by ribozymes that cleave c-myb mRNA. RNA (1996) 0.90
Biomarkers of over-immunosuppression. Clin Pharmacol Ther (2011) 0.89
A vision-based three-dimensional capture system for maxillofacial assessment and surgical planning. Br J Oral Maxillofac Surg (1998) 0.88
X-ray crystallographic observation of "in-line" and "adjacent" conformations in a bulged self-cleaving RNA/DNA hybrid. RNA (2001) 0.88
1-Deazaadenosine: synthesis and activity of base-modified hammerhead ribozymes. Nucleic Acids Res (1998) 0.87
The synthesis and functional evaluation of RNA and DNA polymers having the sequence of Escherichia coli tRNA(fMet). Eur J Biochem (1989) 0.87
Janus molecule I: dichotomous effects of COMT in neuropathic vs nociceptive pain modalities. CNS Neurol Disord Drug Targets (2012) 0.87
Sleep apnea symptoms and risk of temporomandibular disorder: OPPERA cohort. J Dent Res (2013) 0.86
Total chemical synthesis of a ribozyme derived from a group I intron. Proc Natl Acad Sci U S A (1995) 0.86
Structural variation induced by different nucleotides at the cleavage site of the hammerhead ribozyme. Biochemistry (1998) 0.86
Genes from the medicinal leech (Hirudo medicinalis) coding for unusual enzymes that specifically cleave endo-epsilon (gamma-Glu)-Lys isopeptide bonds and help to dissolve blood clots. Mol Gen Genet (1996) 0.86
Cellular uptake properties of a 2'-amino/2'-O-methyl-modified chimeric hammerhead ribozyme targeted to the epidermal growth factor receptor mRNA. Antisense Nucleic Acid Drug Dev (1997) 0.86
Cell-free translation analysis of the vitamin D-dependent calcium binding protein mRNA activity present in total RNA and polysomal extracts from chick intestine. Arch Biochem Biophys (1982) 0.85
Synthesis of 2'-modified nucleotides and their incorporation into hammerhead ribozymes. Nucleic Acids Res (1995) 0.85
Dynamics of neutrophilic NF-kB translocation in relation to IL-8 mRNA expression after major trauma. Inflamm Res (2008) 0.85
Specific pattern of p53 phosphorylation during nitric oxide-induced cell cycle arrest. Oncogene (2000) 0.85
Ultrasonography of gastric ulceration in the dog. Vet Radiol Ultrasound (1997) 0.84
PCR based targeted genomic and cDNA differential display. Genet Anal (1999) 0.83
An oligodeoxyribonucleotide that supports catalytic activity in the hammerhead ribozyme domain. Nucleic Acids Res (1995) 0.83
RecA-mediated affinity capture: a method for full-length cDNA cloning. Biotechniques (1999) 0.83
Alteration of the genes for glycophorin A and B in glycophorin-A-deficient individuals. Eur J Biochem (1988) 0.83
A three-dimensional imaging system for archiving dental study casts: a preliminary report. Int J Adult Orthodon Orthognath Surg (1997) 0.82
Angiozyme: a novel angiogenesis inhibitor. Curr Oncol Rep (2001) 0.81
Three-dimensional modeling for modern diagnosis and planning in maxillofacial surgery. Int J Adult Orthodon Orthognath Surg (1996) 0.81
Inductive interactions regulating body patterning in planarian, revealed by analysis of expression of novel gene scarf. Dev Biol (1998) 0.81